Cortagen

Cortagen is a synthetic short peptide consisting of four amino acids: alanine, glutamic acid, aspartic acid, and proline (Ala-Glu-Asp-Pro, or AEDP). It was developed as part of the Russian peptide bioregulator program led by V.Kh. Khavinson, derived from brain cortex polypeptide complexes Peptide Regulation of Cell Differentiation+1. Unlike larger cortexin, Cortagen is a single, defined tetrapeptide with tissue-specific action EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE "OLD" CHROMATIN+1.

Research focuses on neuroprotection, epigenetic regulation, and tissue regeneration. In cultured lymphocytes from elderly donors (aged 75–88), Cortagen selectively remodeled aging-related chromatin, reactivating silent genes EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON "AGED" HETEROCHROMATIN+1. Animal studies also report improved nerve regeneration after sciatic nerve injury The delayed effect of cortagen on the restoration of injured nerve function+1. The compound is not FDA-approved and lacks human randomized trials, so clinical benefits remain unproven [Neuroprotective effects of peptides bioregulators in people of various age].

Cortagen works by entering the cell nucleus and directly influencing chromatin structure and gene expression, rather than acting through a single cell-surface receptor Peptide Regulation of Cell Differentiation+1. Its four-amino-acid size allows it to pass through nuclear membranes and interact with DNA and histone proteins Peptide Regulation of Cell Differentiation.

In aged human lymphocytes, Cortagen induced decondensation of tightly packed heterochromatin, freeing up previously silenced gene regions, especially in telomeric and pericentromeric areas EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON "AGED" HETEROCHROMATIN+1. This epigenetic opening is thought to restore tissue-specific protein synthesis and stress-protective gene activity Peptide Regulation of Cell Differentiation+1.

Downstream effects include regulation of heat-shock proteins, cytokines, and factors involved in blood clotting and fibrinolysis, as well as activation of hypothalamic-pituitary-pineal and thymus axes [Epigenetic regulation of adaptogenesis by pathology and aging.]. In mouse heart tissue, Cortagen altered the expression of many genes, showing systemic gene-regulatory reach Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray.

Cellular uptake is likely facilitated by peptide transporters PEPT1/PEPT2 and LAT1/LAT2, which recognize short acidic peptides like AEDP Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters.

Documented effects of Cortagen come mainly from preclinical and in vitro studies. They point to several directions:

• Epigenetic remodeling: In cultured lymphocytes from people aged 75–88, Cortagen opened condensed heterochromatin and reactivated ribosomal genes, a change associated with restored protein synthesis EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON "AGED" HETEROCHROMATIN+1.
• Neuroprotection: In a rat model of chronic cerebral ischemia, Cortagen (alone or with cortexin) corrected functional and metabolic brain disturbances [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]. In mice, it modulated anxiety-related behavior and locomotor activity Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice.
• Nerve regeneration: After sciatic nerve injury in rats, Cortagen improved recovery of nerve function, with benefits persisting after treatment ended The delayed effect of cortagen on the restoration of injured nerve function+1.
• Stem cell differentiation: In vitro, AEDP directed pluripotent stem cells toward neural, mesenchymal, and epidermal fates Peptide Regulation of Cell Differentiation.
• Systemic gene regulation: Microarray data from mouse heart showed Cortagen changed expression of many genes outside the brain Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray.

These findings are promising but not yet confirmed in human randomized trials. The overall evidence level is preclinical, with a plausible mechanism but no clinical proof [Neuroprotective effects of peptides bioregulators in people of various age].

Research protocols for Cortagen are not derived from randomized controlled trials. Instead, they reflect empirical use in Russian peptide bioregulator practice. The most common approach is a fixed 10 mg dose, not adjusted for body weight [Neuroprotective effects of peptides bioregulators in people of various age].

The standard protocol is a daily injection of 10 mg, given either intramuscularly or subcutaneously, for 10 days. Some practitioners extend this to 20 days for post-stroke or neurodegenerative applications [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]. Courses are typically repeated every 3–6 months, with 2–3 courses per year [Neuroprotective effects of peptides bioregulators in people of various age].

Animal studies support short-course use. In chronic cerebral ischemia and nerve injury models, Cortagen was given as a time-limited injection series [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]+1. The benefits often appeared gradually over weeks, consistent with epigenetic remodeling rather than immediate receptor activation Peptide Regulation of Cell Differentiation+1.

No oral or intranasal protocol is supported by the available evidence. Intramuscular or subcutaneous injection remains the documented route [Neuroprotective effects of peptides bioregulators in people of various age].

Cortagen is typically supplied as a lyophilized (freeze-dried) powder in 5 mg or 10 mg vials. Short tetrapeptides like Cortagen are sensitive to temperature and moisture, so proper handling matters Peptide Regulation of Cell Differentiation.

For reconstitution, bacteriostatic water (0.9% benzyl alcohol) is commonly used Peptide Regulation of Cell Differentiation. Before mixing, allow the vial and diluent to reach room temperature. Slowly inject the diluent down the inside wall of the vial to avoid foaming, then gently swirl until the powder dissolves. Do not shake or vortex, as that can damage the peptide.

After reconstitution, the solution should be stored refrigerated at 2–8°C, protected from light, and used within 14–30 days. Repeated freeze-thaw cycles should be avoided; if multiple doses are planned, aliquot the solution into separate sterile containers. The lyophilized powder can be stored long-term at -20°C for up to 24 months.

No Cortagen-specific stability data exist; these guidelines follow standard peptide handling practices Peptide Regulation of Cell Differentiation.

No formal drug interaction studies exist for Cortagen, so the following is based on mechanistic reasoning and caution.

• Blood thinning: Cortagen influences expression of fibrinolysis and hemostasis factors, so combining it with anticoagulants (warfarin, heparin) or antiplatelet drugs (aspirin) may increase bleeding risk [Epigenetic regulation of adaptogenesis by pathology and aging.].
• CNS depressants or stimulants: Cortagen modulates anxiety-related behavior in animals, so it may interact with sedatives or stimulants Modulatory Effects of Cortexin and Cortagen on Locomotor Activity and Anxiety-Related Behavior in Mice.
• Antioxidants: Cortagen affects free-radical processes, and combining it with high-dose antioxidants (NAC, vitamin C) could blunt or amplify oxidative signaling Effects of bioactive tetrapeptides on free-radical processes.
• Other peptides: Combining Cortagen with other epigenetic peptides like Epitalon (AEDG) is plausible but should be approached carefully; some practitioners reduce doses when stacking two or more bioregulators Peptide Regulation of Gene Expression: A Systematic Review.

The lack of clinical data means any combination should be monitored closely [Neuroprotective effects of peptides bioregulators in people of various age].

Cycling protocols for Cortagen are based on its epigenetic mechanism, not on receptor desensitization. Because it works by opening chromatin and changing gene expression, continuous exposure might blunt the adaptive signal Peptide Regulation of Cell Differentiation+1.

The standard pattern is a 10-day course of 10 mg daily, followed by a 3–6 month break before repeating. Some protocols add a maintenance phase of 2–3 injections per week for 2–4 weeks after the initial course [Neuroprotective effects of peptides bioregulators in people of various age]. Animal studies also used time-limited injection schedules, showing benefits that persisted after treatment stopped The delayed effect of cortagen on the restoration of injured nerve function+1.

Signs that a break may be needed include diminishing cognitive benefit, new sleep or anxiety symptoms, or injection-site reactions. No withdrawal or rebound has been reported, but long-term safety beyond repeated cycles is unknown Epigenetic Regulation of “Aged” Heterochromatin by Peptide Bioregulator Cortagen.

Cortagen is sometimes combined with other short peptide bioregulators, particularly Epitalon (Ala-Glu-Asp-Gly) and Cortexin. These peptides share epigenetic and neuroprotective pathways Peptide Regulation of Gene Expression: A Systematic Review.

• With Epitalon: Both are short tetrapeptides with similar sequences; Epitalon has more data on pineal/melatonin effects, while Cortagen is more brain cortex–focused. Combining them is a common practitioner approach for age-related cognitive support, though no controlled data exist.
• With Cortexin: Cortexin is a larger bovine cortex extract, not a defined peptide. In a chronic cerebral ischemia model, the combination corrected functional and metabolic brain disorders [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia].
• General stacks: Community protocols sometimes add Vilon or other bioregulators, but due to shared mechanisms, practitioners often reduce doses by 30–50% when stacking two or more Peptide Regulation of Gene Expression: A Systematic Review.

No formal combination studies exist in humans, so any stacking is empirical [Neuroprotective effects of peptides bioregulators in people of various age].

Cortagen is not approved by the FDA or EMA as a pharmaceutical drug. It is not a controlled substance and is not listed on the WADA Prohibited List [Neuroprotective effects of peptides bioregulators in people of various age].

In the United States, it is not included on the FDA 503A Bulks List for pharmacy compounding, making human-use compounding legally uncertain. It is typically sold as a research chemical or through compounding pharmacies under individual prescriber discretion [Neuroprotective effects of peptides bioregulators in people of various age].

Internationally, Cortagen lacks marketing authorization in the EU, UK, and Australia. It emerged from Russian gerontology research and is more commonly found in Russian-language markets. Regulatory status varies by country, and personal import is often restricted [Neuroprotective effects of peptides bioregulators in people of various age].

Safety data for Cortagen are limited; no human randomized controlled trial has systematically assessed adverse events. Animal and in vitro studies did not report severe treatment-related events, but they did not focus on safety endpoints [Cortexin and cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia]+1.

Reported or expected common effects include mild injection-site reactions (pain, redness), transient headache or fatigue, and occasional sleep disturbance if injected late in the day [Neuroprotective effects of peptides bioregulators in people of various age]. Higher-than-standard doses might cause restlessness or agitation due to its neuroactive profile EPIGENETIC MODIFICATION UNDER THE INFLUENCE OF PEPTIDE BIOREGULATORS ON THE "OLD" CHROMATIN.

Theoretical risks include autoimmune flare, epigenetic off-target effects, and possible tumor progression, because Cortagen modifies gene expression and stem cell differentiation Peptide Regulation of Cell Differentiation+1. Pregnancy, breastfeeding, active autoimmune disease, and bleeding disorders are relative contraindications [Neuroprotective effects of peptides bioregulators in people of various age].

Regular monitoring of blood counts, liver and kidney function, and injection-site inspection is suggested for safety surveillance [Neuroprotective effects of peptides bioregulators in people of various age].